Science · 1984 · 599 citations · 27 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunogeneticsImmunoregulationCytokine BiologyCytokine EngineeringCytokine SignalingImmune Cell SignalingBiological Activity FeaturesCytokine Production By Natural Killer CellsCytokine SynthesisEscherichia ColiHalf-life DifferencesImmune Cell Cytokine ProductionNatural Killer Cell Cytokine ProductionSerum Half-life
The IL‑2 gene from Jurkat cells and normal lymphocytes was cloned into *E. coli*, yielding high‑yield recombinant protein that was purified to homogeneity and assayed in vitro and in vivo.
The gene for interleukin-2 was isolated from the Jurkat cell line and from normal peripheral blood lymphocytes and, when inserted in Escherichia coli, was expressed at high concentrations. This interleukin-2 was purified to apparent homogeneity and tested for biological activity in a variety of assays in vitro and in vivo. The recombinant lymphokine supports the growth of murine and human interleukin-2 dependent cell lines, enhances the generation of murine and human cytolytic cells in vitro, and generates lymphokine activated killer cells from murine and human lymphocytes. It has a serum half-life of 2 to 3 minutes in the mouse and significantly enhances the generation of cytolytic cells in vivo after alloimmunization. No functional differences between native and the recombinant interleukin-2 molecules have been detected.
27
Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text
Life Sciences, Immunology, Oncology +15
Structure and expression of a cloned cDNA for human interleukin-2
Tadatsugu Taniguchi, Hiroshi Matsui, Takashi Fujita et al. · Nature · 1983 · 1.2K citations